다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Behavioural neurology, v.2018, 2018년, pp.8320901 -
Lee, Chuo-Yu (Department of Neurology, Mackay Memorial Hospital, Taipei, Taiwan) , Cheng, Shih-Jung (Department of Neurology, Mackay Memorial Hospital, Taipei, Taiwan) , Lin, Hui-Chi (Department of Neurology, Mackay Memorial Hospital, Taipei, Taiwan) , Liao, Yu-Lu (Department of Accounting Information, Takming University of Science and Technology, Taipei, Taiwan) , Chen, Pei-Hao (Department of Neurology, Mackay Memorial Hospital, Taipei, Taiwan)
AI-Helper
Dementia with Lewy bodies (DLB) is a complex, multisymptom disorder. When making decisions regarding the treatment of DLB, the patient's quality of life (QoL) should always be the main consideration. To our knowledge, this is the first review article focusing on the QoL in DLB patients. We searched ...
1 Yang S.-K. Chen W. Su C.-H. Liu C.-H. Incidence and comorbidity of dementia with Lewy bodies: a population-based cohort study Behavioural Neurology 2018 2018 6 7631951 10.1155/2018/7631951
2 Hepp D. H. Vergoossen D. L. E. Huisman E. Distribution and load of amyloid- β pathology in Parkinson disease and dementia with Lewy bodies Journal of Neuropathology & Experimental Neurology 2016 75 10 936 945 10.1093/jnen/nlw070 2-s2.0-84995609193 27516115
3 Ware J. E. Jr Sherbourne C. D. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection Medical Care 1992 30 6 473 483 10.1097/00005650-199206000-00002 1593914
4 Chen H.-M. Chen C.-M. Factors associated with quality of life among older adults with chronic disease in Taiwan International Journal of Gerontology 2017 11 1 12 15 10.1016/j.ijge.2016.07.002 2-s2.0-85007453977
5 Banerjee S. Samsi K. Petrie C. D. What do we know about quality of life in dementia? A review of the emerging evidence on the predictive and explanatory value of disease specific measures of health related quality of life in people with dementia International Journal of Geriatric Psychiatry 2009 24 1 15 24 10.1002/gps.2090 2-s2.0-61749089957 18727132
6 Mueller C. Ballard C. Corbett A. Aarsland D. The prognosis of dementia with Lewy bodies Lancet Neurology 2017 16 5 390 398 10.1016/S1474-4422(17)30074-1 2-s2.0-85016020307 28342649
7 Thomas P. Lalloué F. Preux P. M. Dementia patients caregivers quality of life: the PIXEL study International Journal of Geriatric Psychiatry 2006 21 1 50 56 10.1002/gps.1422 2-s2.0-31344447983 16323256
8 Figari-Jordan R. Anderson K. Gruber-Baldini A. Comparison of quality of life and disability in three different dementias (P07.180) Neurology 2012 78 Meeting Abstracts 1, article P07.180 10.1212/WNL.78.1_MeetingAbstracts.P07.180
9 Boström F. Jönsson L. Minthon L. Londos E. Patients with dementia with lewy bodies have more impaired quality of life than patients with Alzheimer disease Alzheimer Disease & Associated Disorders 2007 21 2 150 154 10.1097/WAD.0b013e318065c4a9 2-s2.0-34249939044 17545741
10 Sands L. P. Ferreira P. Stewart A. L. Brod M. Yaffe K. What explains differences between dementia patients’ and their caregivers’ ratings of patients’ quality of life? The American Journal of Geriatric Psychiatry 2004 12 3 272 280 10.1097/00019442-200405000-00006 2-s2.0-84903148811 15126228
11 Karlawish J. H. T. Casarett D. Klocinski J. Clark C. M. The relationship between caregivers’ global ratings of Alzheimer’s disease patients’ quality of life, disease severity, and the caregiving experience Journal of the American Geriatrics Society 2001 49 8 1066 1070 10.1046/j.1532-5415.2001.49210.x 2-s2.0-0034869330 11555068
12 Yang F. Dawes P. Leroi I. Gannon B. Measurement tools of resource use and quality of life in clinical trials for dementia or cognitive impairment interventions: a systematically conducted narrative review International Journal of Geriatric Psychiatry 2018 33 2 e166 e176 10.1002/gps.4771 2-s2.0-85040711147 28796303
13 Logsdon R. G. Gibbons L. E. McCurry S. M. Teri L. Quality of life in Alzheimer’s disease: patient and caregiver reports Journal of Mental health and Aging 1999 5 21 32
14 Smith S. Lamping D. Banerjee S. Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology Health Technology Assessment 2005 9 10 10.3310/hta9100
15 The EuroQol Group EuroQol - a new facility for the measurement of health-related quality of life Health Policy 1990 16 3 199 208 10.1016/0168-8510(90)90421-9 2-s2.0-0025688231 10109801
16 Jenkinson C. Layte R. Jenkinson D. A shorter form health survey: can the SF-12 replicate results from the SF-36 in longitudinal studies? Journal of Public Health 1997 19 2 179 186 10.1093/oxfordjournals.pubmed.a024606
17 Mougias A. A. Politis A. Lyketsos C. G. Mavreas V. G. Quality of life in dementia patients in Athens, Greece: predictive factors and the role of caregiver-related factors International Psychogeriatrics 2011 23 3 395 403 10.1017/S1041610210001262 2-s2.0-79960581967 20701816
18 Ballard C. Holmes C. McKeith I. Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer’s disease American Journal of Psychiatry 1999 156 7 1039 1045 10.1176/ajp.156.7.1039 10401449
19 Ferman T. J. Smith G. E. Boeve B. F. Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer’s disease The Clinical Neuropsychologist 2006 20 4 623 636 10.1080/13854040500376831 2-s2.0-33748797132 16980250
20 Ferman T. J. Arvanitakis Z. Fujishiro H. Pathology and temporal onset of visual hallucinations, misperceptions and family misidentification distinguishes dementia with Lewy bodies from Alzheimer’s disease Parkinsonism & Related Disorders 2013 19 2 227 231 10.1016/j.parkreldis.2012.10.013 2-s2.0-84873734416 23182311
21 Thaipisuttikul P. Lobach I. Zweig Y. Gurnani A. Galvin J. E. Capgras syndrome in dementia with Lewy bodies International Psychogeriatrics 2013 25 5 843 849 10.1017/S1041610212002189 2-s2.0-84875440399 23211760
22 Erskine D. Thomas A. J. Taylor J. P. Neuronal loss and Α-synuclein pathology in the superior colliculus and its relationship to visual hallucinations in dementia with Lewy bodies The American Journal of Geriatric Psychiatry 2017 25 6 595 604 10.1016/j.jagp.2017.01.005 2-s2.0-85012882519 28190674
23 López-Pousa S. Vilalta-Franch J. Garre-Olmo J. Pons S. Cucurella M. G. Characterisation and prevalence of the psychological and behavioural symptoms in patients with dementia Revista de Neurologia 2007 45 11 683 688 18050101
24 Tzeng R.-C. Tsai C.-F. Wang C.-T. Wang T.-Y. Chiu P.-Y. Delusions in patients with dementia with Lewy bodies and the associated factors Behavioural Neurology 2018 2018 8 6707291 10.1155/2018/6707291
25 Mosimann U. P. Rowan E. N. Partington C. E. Characteristics of visual hallucinations in Parkinson disease dementia and dementia with Lewy bodies The American Journal of Geriatric Psychiatry 2006 14 2 153 160 10.1097/01.JGP.0000192480.89813.80 2-s2.0-32444434310 16473980
26 Cummings J. Isaacson S. Mills R. Pimavanserin for patients with Parkinson’s disease psychosis: a randomised, placebo-controlled phase 3 trial The Lancet 2014 383 9916 533 540 10.1016/S0140-6736(13)62106-6 2-s2.0-84895904524
27 Baquero M. Martin N. Depressive symptoms in neurodegenerative diseases World Journal of Clinical Cases 2015 3 8 682 693 10.12998/wjcc.v3.i8.682 26301229
28 Ornstein K. Gaugler J. E. Devanand D. P. Scarmeas N. Zhu C. Stern Y. The differential impact of unique behavioral and psychological symptoms for the dementia caregiver: how and why do patients’ individual symptom clusters impact caregiver depressive symptoms? The American Journal of Geriatric Psychiatry 2013 21 12 1277 1286 10.1016/j.jagp.2013.01.062 2-s2.0-84888639310 24206939
29 Yamane Y. Sakai K. Maeda K. Dementia with Lewy bodies is associated with higher scores on the Geriatric Depression Scale than is Alzheimer’s disease Psychogeriatrics 2011 11 3 157 165 10.1111/j.1479-8301.2011.00368.x 2-s2.0-80053138934 21951956
30 Kurisu K. Terada S. Oshima E. Comparison of QOL between patients with different degenerative dementias, focusing especially on positive and negative affect International Psychogeriatrics 2016 28 8 1355 1361 10.1017/S1041610216000491 2-s2.0-84961891782 27020694
31 Pillai J. A. Leverenz J. B. Sleep and neurodegeneration: a critical appraisal Chest 2017 151 6 1375 1386 10.1016/j.chest.2017.01.002 2-s2.0-85020515186 28087304
32 Peyron C. Tighe D. K. van den Pol A. N. Neurons containing hypocretin (orexin) project to multiple neuronal systems Journal of Neuroscience 1998 18 23 9996 10015 10.1523/JNEUROSCI.18-23-09996.1998 9822755
33 Wennström M. Londos E. Minthon L. Nielsen H. M. Altered CSF orexin and α-synuclein levels in dementia patients Journal of Alzheimer's Disease 2012 29 1 125 132 10.3233/JAD-2012-111655 2-s2.0-84858136734 22207004
34 Ferman T. J. Boeve B. F. Smith G. E. Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies Neurology 2011 77 9 875 882 10.1212/WNL.0b013e31822c9148 2-s2.0-80055077766 21849645
35 Pao W. C. Boeve B. F. Ferman T. J. Polysomnographic findings in dementia with Lewy bodies The Neurologist 2013 19 1 1 6 10.1097/NRL.0b013e31827c6bdd 2-s2.0-84872111118 23269098
36 Allan L. McKeith I. Ballard C. Kenny R. A. The prevalence of autonomic symptoms in dementia and their association with physical activity, activities of daily living and quality of life Dementia and Geriatric Cognitive Disorders 2006 22 3 230 237 10.1159/000094971 2-s2.0-33748211237 16902277
37 Berrios G. E. Campbell C. Politynska B. E. Autonomic failure, depression and anxiety in Parkinson’s disease British Journal of Psychiatry 1995 166 6 789 792 10.1192/bjp.166.6.789 7663829
38 MCHORNEY C. O. L. L. E. E. N. A. JOHNE W. JR. ANASTASIAE R. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs Medical Care 1993 31 3 247 263 10.1097/00005650-199303000-00006 2-s2.0-0027569430 8450681
39 Fanciulli A. Strano S. Colosimo C. Caltagirone C. Spalletta G. Pontieri F. E. The potential prognostic role of cardiovascular autonomic failure in α -synucleinopathies European Journal of Neurology 2013 20 2 231 235 10.1111/j.1468-1331.2012.03819.x 2-s2.0-84872395688 22834919
40 Oka H. Morita M. Onouchi K. Yoshioka M. Mochio S. Inoue K. Cardiovascular autonomic dysfunction in dementia with Lewy bodies and Parkinson’s disease Journal of the Neurological Sciences 2007 254 1-2 72 77 10.1016/j.jns.2007.01.002 2-s2.0-33847283293 17306830
41 Oka H. Yoshioka M. Morita M. Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in Lewy body disease Neurology 2007 69 14 1460 1465 10.1212/01.wnl.0000277450.49788.82 2-s2.0-34848881084 17909159
42 Horimoto Y. Matsumoto M. Akatsu H. Autonomic dysfunctions in dementia with Lewy bodies Journal of Neurology 2003 250 5 530 533 10.1007/s00415-003-1029-9 2-s2.0-0037903338 12736730
43 Thaisetthawatkul P. Boeve B. F. Benarroch E. E. Autonomic dysfunction in dementia with Lewy bodies Neurology 2004 62 10 1804 1809 10.1212/01.WNL.0000125192.69777.6D 2-s2.0-2442672786 15159482
44 Freeman R. Wieling W. Axelrod F. B. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome Autonomic Neuroscience 2011 161 1-2 46 48 10.1016/j.autneu.2011.02.004 2-s2.0-79953763846 21393070
45 Boot B. P. Comprehensive treatment of dementia with Lewy bodies Alzheimer's Research & Therapy 2015 7 1 p. 45 10.1186/s13195-015-0128-z 2-s2.0-84931268112 26029267
46 Kenny R. Shaw F. E. O'Brien J. T. Scheltens P. H. Kalaria R. Ballard C. Carotid sinus syndrome is common in dementia with Lewy bodies and correlates with deep white matter lesions Journal of Neurology, Neurosurgery & Psychiatry 2004 75 7 966 971 10.1136/jnnp.2003.023812 2-s2.0-2942625364 15201351
47 Stubendorff K. Hansson O. Minthon L. Londos E. Differences in survival between patients with dementia with Lewy bodies and patients with Alzheimer’s disease - measured from a fixed cognitive level Dementia and Geriatric Cognitive Disorders 2012 32 6 408 416 10.1159/000335364 2-s2.0-84856805730
48 Darwish M. Kirby M. Hellriegel E. T. Robertson P. Jr Armodafinil and modafinil have substantially different pharmacokinetic profiles despite having the same terminal half-lives Clinical Drug Investigation 2009 29 9 613 623 10.2165/11315280-000000000-00000 2-s2.0-68949098308 19663523
49 Lapid M. I. Kuntz K. M. Mason S. S. Efficacy, safety, and tolerability of armodafinil therapy for hypersomnia associated with dementia with Lewy bodies: a pilot study Dementia and Geriatric Cognitive Disorders 2017 43 5-6 269 280 10.1159/000471507 2-s2.0-85018789355 28448998
50 Larsson V. Engedal K. Aarsland D. Wattmo C. Minthon L. Londos E. Quality of life and the effect of memantine in dementia with Lewy bodies and Parkinson’s disease dementia Dementia and Geriatric Cognitive Disorders 2011 32 4 227 234 10.1159/000334523 2-s2.0-82055175125 22122992
51 Inskip M. Mavros Y. Sachdev P. S. Fiatarone Singh M. A. Exercise for individuals with Lewy body dementia: a systematic review PLoS One 2016 11 6, article e0156520 10.1371/journal.pone.0156520 2-s2.0-84973473814 27258533
52 Bonanni L. Cagnin A. Agosta F. The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design Neurological Sciences 2017 38 1 83 91 10.1007/s10072-016-2713-8 2-s2.0-84987660259 27624723
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.